The invention has an object to provide a novel quinoline derivative of the following formula (I) which has no benzyl group in the 5-position and shows hypoglycemic effect, particularly, by oral administration: STR1 in which R1 is hydrogen; an a
-
(2008/06/13)
More Articles about upstream products of 179068-87-2